These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32379048)

  • 1. Web-Based Intervention Effects on Mild Cognitive Impairment Based on Apolipoprotein E Genotype: Quasi-Experimental Study.
    Tsolaki AC; Tsolaki M; Pandria N; Lazarou E; Gkatzima O; Zilidou V; Karagianni M; Iakovidou-Kritsi Z; Kimiskidis VK; Bamidis PD
    J Med Internet Res; 2020 May; 22(5):e14617. PubMed ID: 32379048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
    O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
    J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis.
    Mu T; Wei J; Sun J; Jin J; Zhang T; Wu H; Su B
    Chin Med J (Engl); 2022 Nov; 135(22):2677-2686. PubMed ID: 36719356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4.
    Kutner KC; Erlanger DM; Tsai J; Jordan B; Relkin NR
    Neurosurgery; 2000 Sep; 47(3):651-7; discussion 657-8. PubMed ID: 10981753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
    Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
    Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
    Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
    Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
    Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
    Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yue JK; Robinson CK; Burke JF; Winkler EA; Deng H; Cnossen MC; Lingsma HF; Ferguson AR; McAllister TW; Rosand J; Burchard EG; Sorani MD; Sharma S; Nielson JL; Satris GG; Talbott JF; Tarapore PE; Korley FK; Wang KKW; Yuh EL; Mukherjee P; Diaz-Arrastia R; Valadka AB; Okonkwo DO; Manley GT;
    Brain Behav; 2017 Sep; 7(9):e00791. PubMed ID: 28948085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of APOE in mild cognitive impairment.
    Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
    Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episodic Memory and Hippocampal Volume Predict 5-Year Mild Cognitive Impairment Conversion in Healthy Apolipoprotein ε4 Carriers.
    Abraham M; Seidenberg M; Kelly DA; Nielson KA; Woodard JL; Carson Smith J; Durgerian S; Rao SM
    J Int Neuropsychol Soc; 2020 Aug; 26(7):733-738. PubMed ID: 32131913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).
    Scarmeas N; Habeck C; Anderson KE; Hilton J; Devanand DP; Pelton GH; Tabert MH; Flynn J; Park A; Ciappa A; Tycko B; Stern Y
    Am J Geriatr Psychiatry; 2004; 12(6):596-605. PubMed ID: 15545327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.